Pill politics

The Food and Drug Administration recently approved over the counter sale of a drug nicknamed the "morning after pill." Midmorning's guests talk about the political controversy at the FDA and why some pharmacists might not want to allow the drug's sale.

Guests

• Timothy Tracy: Professor of pharmacy at the University of Minnesota.
• Susan Wood: Former assistant FDA commissioner for women's health and director of the Office of Women's Health. She resigned the FDA over its decision on Plan B.

Resources

• Barr Laboratories Plan B statement
• FDA statement on Plan B, August 26
• About Timothy Tracy
• About Susan Wood